Ana worked as a journalist in health-specialized weekly newspapers and consumer health monthly magazines. She has been involved in different patient advocacy groups, first as a volunteer and later on within the communication department. She has worked as PR and press consultant in the health department of an international PR agency developing communication strategies for the main pharmaceutical companies. She holds a bachelor degree in journalism from Universidad Complutense of Madrid and a Master’s degree in Audiovisual Communication from Universidad Antonio de Nebrija, in Madrid.
Ana has been involved in the elaboration of two books focused on patients with cancer as a co-writer and editorial coordinator.
Myeloma Patients Europe (MPE) is an umbrella organisation of myeloma patient groups and associations from across Europe and acts as an umbrella organisation for existing local and national myeloma associations and its members come from nearly 30 different countries. MPE aims to collaborate on projects to the benefit of the myeloma community, exchange information and best practice, develope existing patient groups and ensure patients across Europe receive timely access to new treatment.MPE is a network of European myeloma patient organisations. It supports national patient organisations to improve treatment and access for patients in their countries and helps inform and raise awareness on a European level through its educational programmes.
Reasonable agreements between patient advocacy and the pharmaceutical industry - presentation
20 Nov 2018
Reasonable Legal Agreements between Patient Advocates and Pharmaceutical Companies (Leaflet)
20 Mar 2019
13 Feb 2020 Research report